Valerie J. Ludbrook
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough
Ludbrook, Valerie J.; Hanrott, Kate E.; Kreindler, James L.; Marks-Konczalik, Joanna E.; Bird, Nick P.; Hewens, Debbie A.; Beerahee, Misba; Behm, David J.; Morice, Alyn; McGarvey, Lorcan; Parker, Sean M.; Birring, Surinder S.; Smith, Jaclyn
Authors
Kate E. Hanrott
James L. Kreindler
Joanna E. Marks-Konczalik
Nick P. Bird
Debbie A. Hewens
Misba Beerahee
David J. Behm
Professor Alyn Morice A.H.Morice@hull.ac.uk
Foundation Chair and Professor of Respiratory Medicine
Lorcan McGarvey
Sean M. Parker
Surinder S. Birring
Jaclyn Smith
Abstract
Objective Airway sensory nerves involved in the cough reflex are activated by adenosine triphosphate (ATP) agonism of P2X purinoceptor 3 (P2X3) receptors. Transient receptor potential vanilloid 4 (TRPV4) channel activation causes ATP release from airway cells, and it is hypothesised that a TRPV4-ATP-P2X3 axis contributes to chronic cough. An adaptive study was run to determine if TRPV4 inhibition, using the selective TRPV4 channel blocker GSK2798745, was effective in reducing cough. Methods A two-period randomised, double blinded, placebo-controlled crossover study was designed with interim analyses for futility and sample size adjustment. Refractory chronic cough patients received either GSK2798745 or placebo once daily for 7 days with a washout between treatments. Pharmacokinetic samples were collected for analysis of GSK2798745 at end of study. The primary end-point was total cough counts assessed objectively during day-time hours (10 h) following 7 days of dosing. Results Interim analysis was performed after 12 participants completed both treatment periods. This showed a 32% increase in cough counts on Day 7 for GSK2798745 compared to placebo; the pre-defined negative criteria for the study were met and the study was stopped. At this point 17 participants had been enrolled (mean 61 years; 88% female), and 15 had completed the study. Final study results for posterior median cough counts showed a 34% (90% credible interval: −3%, +85%) numerical increase for GSK2798745 compared to placebo. Conclusion There was no evidence of an anti-tussive effect of GSK2798745. The study design allowed the decision on lack of efficacy to be made with minimal participant exposure to the investigational drug.
Citation
Ludbrook, V. J., Hanrott, K. E., Kreindler, J. L., Marks-Konczalik, J. E., Bird, N. P., Hewens, D. A., …Smith, J. (2021). Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough. ERJ Open Research, 7(3), Article 00269-2021. https://doi.org/10.1183/23120541.00269-2021
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 4, 2021 |
Online Publication Date | Aug 2, 2021 |
Publication Date | Jul 1, 2021 |
Deposit Date | Feb 9, 2023 |
Publicly Available Date | Feb 10, 2023 |
Journal | ERJ Open Research |
Electronic ISSN | 2312-0541 |
Publisher | European Respiratory Society |
Peer Reviewed | Peer Reviewed |
Volume | 7 |
Issue | 3 |
Article Number | 00269-2021 |
DOI | https://doi.org/10.1183/23120541.00269-2021 |
Public URL | https://hull-repository.worktribe.com/output/4064457 |
Files
Published article
(582 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0
Copyright Statement
Copyright ©The authors 2021.
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
You might also like
Reflux aspiration and lung disease
(2018)
Book
COVID-19 controversy: when to intubate?
(2021)
Journal Article
Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
(2021)
Journal Article
Acute and chronic cough
(2005)
Book
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search